This study mainly evaluated the efficacy and safety of autologous stem cell transplantation for the treatment of AL amyloidosis, the role of induction and maintenance therapy in autologous stem cell transplantation, and the long-term efficacy and prognosis risk factors of autologous stem cell transplantation for the treatment of AL amyloidosis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
overall survival
Timeframe: 5 years
progression-free survival
Timeframe: 5 years
hematological complete response rate
Timeframe: 1 year
organ response rate
Timeframe: 1 year